BIOMAT Database Logo BIOMAT Database Logo

Ambroxol inhibits histamine release from human adenoidal mast cells. 1998

G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Institute of Pharmacology and Toxicology, Medical Faculty, RWTH, Aachen, Germany.

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D003189 p-Methoxy-N-methylphenethylamine A potent mast cell degranulator. It is involved in histamine release. Agent 48-80,BW 48-80,Compound 48-80,Preparation 48-80,Agent 48 80,Agent 4880,BW 48 80,BW 4880,Compound 48 80,Compound 4880,Preparation 48 80,Preparation 4880,p Methoxy N methylphenethylamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005100 Expectorants Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. Expectorant,Mucolytic,Mucolytic Agent,Mucolytic Agents,Mucolytics,Agent, Mucolytic,Agents, Mucolytic
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000234 Adenoids A collection of lymphoid nodules on the posterior wall and roof of the NASOPHARYNX. Pharyngeal Tonsils,Tonsil, Pharyngeal,Pharyngeal Tonsil,Adenoid,Tonsils, Pharyngeal

Related Publications

G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells.
February 1999, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Histamine release from human adenoidal and mesenteric mast cells induced by bacterial antigens.
April 1988, Agents and actions,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Histamine secretion from human mesenteric and adenoidal mast cells.
January 1992, Archivum immunologiae et therapiae experimentalis,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Comparison of histamine release from human blood monocytes, lymphocytes, adenoidal and skin mast cells.
January 1995, International archives of allergy and immunology,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Heparin inhibits histamine release from canine mast cells.
April 1993, The American journal of physiology,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Low density lipoprotein (LDL) inhibits histamine release from human mast cells.
October 1987, Biochemical and biophysical research communications,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Pycnogenol inhibits the release of histamine from mast cells.
January 2003, Phytotherapy research : PTR,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Auranofin inhibits histamine release from rat peritoneal mast cells.
January 1990, International journal of immunopharmacology,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Forskolin inhibits the release of histamine from human basophils and mast cells.
April 1986, Agents and actions,
G Zwadlo-Klarwasser, and M D Servais, and W Schmutzler, and P Brosthardt, and U Braam
Histamine release from human pulmonary mast cells.
April 1982, Agents and actions,
Copied contents to your clipboard!